Stock Analysis on Net
Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company was transferred to the archive: financial data is no longer updated!

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Celgene Corp. for $13.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Cash Flow Statement
Quarterly Data

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Celgene Corp., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
3 months ended: Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Net income (loss)
Depreciation
Amortization
Impairment charges
Deferred income taxes
Change in value of contingent consideration and success payments
Gain on sale of business
Net (gain) loss on sales of debt securities available-for-sale
Fair value adjustments on equity investments
Share-based compensation expense
Share-based employee benefit plan expense
Derivative instruments
Other, net
Accounts receivable
Inventory
Other operating assets
Accounts payable and other operating liabilities
Income tax payable
Payment of contingent consideration
Deferred revenue
Change in current assets and liabilities, excluding the effect of acquisitions and disposals
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Proceeds from sales of debt securities available-for-sale
Purchases of debt securities available-for-sale
Capital expenditures
Proceeds from sales of equity investment securities
Purchases of equity investment securities
Payments for acquisition of businesses, net of cash acquired
Payment for acquisition of intangible asset
Other
Net cash (used in) provided by investing activities
Payment for treasury shares
Proceeds from short-term borrowing
Principal repayments on short-term borrowing
Proceeds from issuance of long-term debt
Principal repayments on current portion of long-term debt
Net proceeds (payments) from common equity put options
Payment of contingent consideration
Net proceeds from share-based compensation arrangements
Excess tax benefit from share-based compensation arrangements
Net cash provided by (used in) financing activities
Effect of currency rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents

Based on: 10-Q (filing date: 2019-10-31), 10-Q (filing date: 2019-07-30), 10-Q (filing date: 2019-04-25), 10-K (filing date: 2019-02-26), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-07), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-10), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-05-03), 10-K (filing date: 2016-02-11), 10-Q (filing date: 2015-11-05), 10-Q (filing date: 2015-07-28), 10-Q (filing date: 2015-04-30), 10-K (filing date: 2015-02-20), 10-Q (filing date: 2014-10-28), 10-Q (filing date: 2014-07-29), 10-Q (filing date: 2014-04-29).

Cash flow statement item Description The company
Net cash provided by (used in) operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Celgene Corp.’s net cash provided by (used in) operating activities increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Celgene Corp.’s net cash (used in) provided by investing activities increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Celgene Corp.’s net cash provided by (used in) financing activities decreased from Q1 2019 to Q2 2019 but then increased from Q2 2019 to Q3 2019 exceeding Q1 2019 level.